Tralement Versus a Fixed-dose Trace Element Combination Product of Zinc, Copper, and Selenious Acid to Evaluate Product Safety in Pediatric Patients > 3 to 17 Years of Age Requiring Long-term Parenteral Nutrition
Condition: Manganese Safety in Pediatric Patients Interventions: Drug: Tralement; Drug: Fixed-dose trace element combination product of zinc, copper, and selenious acid Sponsor: American Regent, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials